Long-Term Outcomes of a Japanese Prospective Multicenter Registry Using a Heparin-Bonded Expanded Polytetrafluoroethylene Graft for Above-the-Knee Femoropopliteal Bypasses
CONCLUSIONS: This multicenter prospective registry-based analysis showed sustained excellent clinical improvement and secondary patency for up to 8 years following PROPATEN®-based AKFPB. PROPATEN®constitutes a durable and good revascularization option for complex superficial femoral artery lesions, especially when endovascular treatment is inappropriate or an adequate venous conduit is unavailable.PMID:38616124 | DOI:10.1253/circj.CJ-24-0135
Source: Circulation Journal - Category: Cardiology Authors: Naoki Fujimura Hideaki Obara Kentaro Matsubara Naoki Toya Naoko Isogai Hidemitsu Ogino Taku Fujii Toshifumi Kudo Yuji Kanaoka Hirohisa Harada Hidetoshi Uchiyama Atsushi Guntani Tatsuya Shimogawara Susumu Watada Shintaro Shibutani Takao Ohki Japanese Bypas Source Type: research
More News: Cardiology | Japan Health